Jing Cheng, Ph.D.

Personal Health Monitoring Systems: from Molecule to Organ

Jing Cheng, Tsinghua University, Beijing, China

In order for better health monitoring, variety of biomedical engineering technologies ranging from molecule to organ levels have been developed based on Traditional Chinese Medicine (TCM) and modern measurement methodologies.

Traditional Chinese Medicine sorts human population into nine constitutions including one balanced constitution and eight unbalanced constitutions (Qi- deficiency, Yang-deficiency, Yin-deficiency, Phlegm-dampness, Damp-heat, Blood stasis, Qi-stagnation and Special intrinsic constitution). More importantly, certain constitutions are correlated with a likelihood for developing certain diseases. The combined analysis of one’s constitution and SNP markers provides an effective assessment of one’s susceptibility to certain diseases.

In order to detect the disease signs as early as technologically possible, the methods/ tools that enable self-checkup and test at home on a daily basis were developed, which include blood pressure, body mass index, body fat, blood biochemicals, and urine tests. Especially, we have developed an imaging-based eye white analysis system, consisting of a digital imaging device capable of capturing eye images and an image processing system which enables the recognition, extraction and analysis of the images. The processed eye-image systems can be integrated with an expert database including TCM information, biochemical features form bio-chips, real-time data from physiological measurement devices for the personal health monitoring in a continuous way.


Jing ChengCheung Kong Professor at Tsinghua University School of Medicine, Director of National Engineering Research Center for Beijing Biochip Technology, Member of the Chinese Academy of Engineering,Member of the International Academy of Sciences for Europe and Asia and National “Thousand Talents” Distinguished Professor.

Dr. Cheng received his Ph.D. degree in Forensic Sciences from the University of Strathclyde (UK) in 1992. He has been engaged and made great achievements in biotechnology researches related to both basic and clinical medicine, especially in the field of biochip technology. He has established series of biochip-based molecular typing systems for disease prevention, diagnosis and prognosis; and developed a variety of biochips for the analysis of genes, proteins and cells. Some of these chips have been certified by the Chinese Food and Drug Administration and applied in the hospital. Additionally, he has been responsible in developing and manufacturing a full line of instruments for biochips.

Dr. Cheng published 130 peer-reviewed papers, edited 8 books, obtained 113 national patent, 108 European and US patents. He received many awards including the Second Prize of the National Awards for Technological Innovation.